ATLANTA, GA—In a finding that sheds some light on just how semaglutide helps the heart, patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes see ...

(RTTNews) - Novo Nordisk (NVO) reported headline results from STEP UP, a phase 3b trial in the global STEP programme. The trial achieved primary endpoint by demonstrating a statistically significant ...

Clinical trials are an essential part of improving stroke care for patients, but each trial can also require years of planning and tens of millions of dollars from start to finish. Two University of ...

A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over ...

Obesity prevalence continues to increase, with the global number of affected individuals expected to double from 988 million in 2020 to almost 2 billion in 2035 1. This makes obesity one of the ...

Credit: Getty Images Until semaglutide, weight loss of 15% to avoid obesity-related complications was only achieved through bariatric surgery. In clinical trials, semaglutide proved to be superior to ...